K. Rꢀck-Braun et al.
FULL PAPERS
n˜ =3073, 2957, 2936, 2942, 2924, 2891, 2865, 2143, 1744, 1537, 1462, 1383,
Rf =0.35 (hexane/EtOAc 5:1); m.p.: 119–1228C; IR (ATR): n˜ =3523,
3059, 3038, 2978, 2929, 2902, 2853, 1714, 1609, 1571, 1553, 1509, 1475,
1464, 1443, 1366, 1338, 1275, 1253, 1188, 1179, 1143, 1104, 1019, 986, 897,
1178, 1154, 996, 883, 797, 754 cmÀ1 1H NMR (400 MHz, CDCl3): d=7.03
;
(d, J=3.6 Hz, 1H), 6.60 (dq, J=1.1 Hz, 3.6 Hz, 1H), 2.45 (d, J=1.1 Hz,
3H), 1.12 ppm (s, 21H); 13C NMR (100 MHz, CDCl3): d=141.9, 132.7,
125.2, 121.4, 100.0, 94.4, 18.8, 15.5, 11.5 ppm; HRMS (EI): m/z (%) calcd
for C16H26SSi: 278.1524; found: 278.1517; elemental analysis: calcd (%)
for C16H26SSi (278.5): C 69.00, H 9.41; found: C 68.88, H 9.41.
854, 831, 762 cmÀ1 1H NMR (400 MHz, CDCl3): d=8.05 (d, J=8.4 Hz,
;
6H), 7.56 (d, J=8.5 Hz, 6H) 7.53–7.45 (m, 6H), 7.28 (brs, 1H), 7.14 (brs,
1H), 6.93–6.90 (m, 2H), 4.39 (q, J=7.1 Hz, 6H), 3.83 (s, 3H), 2.21–2.20
(m, 12H), 1.95 (s, 3H), 1.94 (s, 3H) 1.40 ppm (t, J=7.1 Hz, 9H);
13C NMR (100 MHz, CDCl3): d=166.6, 159.7, 153.8, 149.5, 143.4, 142.5,
140.5, 131.7, 131.6, 129.9, 128.8, 127.1, 126.2, 125.6, 125.3, 125.2, 121.8,
121.2 (2C), 120.7, 114.5, 93.8, 81.7, 61.1, 55.5, 46.8 (2C), 39.7, 39.5, 14.7,
14.6, 14.5 ppm; HRMS (EI): m/z (%) calcd for C67H56F6O7S2 [M+À2H]:
1150.3372; found: 1150.3321; elemental analysis: calcd (%) for
C67H58F6O7S2 (1153.29): C 69.78, H 5.07; found: C 70.07, H 5.33.
1-[5-(4-Methoxyphenyl)-2-methylthienyl-3-yl]-2-[2-methyl-5-(triisopropyl-
silyl-ethynyl)thien-3-yl]-3,3,4,4,5,5-hexafluorocyclopentene
(15b):
A
thick-walled Schlenk tube was evacuated, heated under vacuum, and re-
filled with argon three times. Then, the Schlenk tube was charged under
a positive pressure of argon with dithienylethene 4 (50.0 mg, 98.2 mmol),
[PdCl2ACHTUNGTRENNUNG(CH3CN)2] (2.5 mg, 9.8 mmol, 10 mol%), X-Phos (14.0 mg,
29.4 mmol, 30 mol%), K3PO4 (54.1 mg, 255 mmol, 2.60 equiv), and aceto-
nitrile (0.20 mL). The bluish suspension was degassed (5 min, ultrasound)
and stirred for 30 min, before triisopropylsilylacetylene (10b) (23.2 mg,
127 mmol, 1.3 equiv) was added using a syringe. The Schlenk tube was
sealed with a teflon valve, and the resulting suspension was stirred for
24 h at 808C (TLC monitoring). The resulting brown suspension was al-
lowed to reach room temperature, was diluted with water (5 mL), and ex-
tracted with CH2Cl2 (3ꢄ15 mL). The combined organic layers were dried
(MgSO4) and evaporated in vacuo. The crude product was purified by
flash chromatography on silica gel using hexane/EtOAc (10:1) to give
product 15b as a bluish solid (37.0 mg, 56.5 mmol, 58%) besides by-prod-
uct 16; mixture of isomers (O-isomer : C-isomer ꢀ 95:5 as determined
by 1H NMR). C-isomer: Rf =0.73 (hexane/CH2Cl2, 2:1); O-isomer: Rf =
0.67 (hexane/CH2Cl2, 2:1); m.p.: 104–1078C; IR (ATR): n˜ =2956, 2943,
2865, 2146, 1709, 1610, 1572, 1554, 1515, 1473, 1463, 1441, 1420, 1337,
1300, 1273, 1253, 1192, 1178, 1137, 1112, 1090, 1051, 1037, 987, 883, 823,
Dithienylethene-linker-conjugate 2: A thick-walled Schlenk tube was
evacuated, heated under vacuum, and refilled with argon three times.
Then, the Schlenk tube was charged under a positive pressure of argon
with dithienylethene 6 (30.0 mg, 47.6 mmol), [PdCl2ACTHNUGTRNE(UNG CH3CN)2] (1.2 mg,
4.8 mmol, 10 mol%), X-Phos (6.8 mg, 14.3 mmol, 30 mol%), K3PO4
(26.1 mg, 123 mmol, 2.60 equiv), and acetonitrile (0.01 mL). The bluish
suspension was degassed (5 min, ultrasound) and stirred for 30 min
before compound 5 (42.0 mg, 61.9 mmol, 1.30 equiv) was added. After-
wards, the Schlenk tube was sealed with a teflon valve and the suspension
was stirred at 808C for 4 h (TLC monitoring). Then, the resulting suspen-
sion was allowed to reach room temperature and was diluted with water
(15 mL) and EtOAc (15 mL). The aqueous phase was separated and ex-
tracted with EtOAc (3ꢄ15 mL). The combined organic layers were dried
(MgSO4) and evaporated in vacuo. The crude product was purified by
flash chromatography on silica gel using hexane/EtOAc (5:1) to give
compound 2 as a bluish solid (45.0 mg, 36.6 mmol, 76%); mixture of iso-
mers (O-isomer : C-isomer ꢀ95:5 as determined by 1H NMR). O/C-
isomer: Rf =0.32 (hexane/EtOAc, 5:1); m.p.: 140–1438C; IR (ATR): n˜ =
2979, 2932, 2902, 2854, 1716, 1609, 1515, 1336, 1277, 1255, 1188, 1106,
735 cmÀ1 1H NMR (400 MHz, CDCl3): d=7.48–7.44 (m, 2H), 7.21 (brs,
;
1H), 7.12 (brs, 1H), 6.93–6.90 (m, 2H), 3.84 (s, 3H), 1.95 (s, 3H), 1.90 (s,
3H), 1.12ppm (s, 21H); 13C NMR (100 MHz, CDCl3): d=159.7, 143.2,
142.5, 140.5, 131.9, 127.1, 126.3, 125.6, 125.0, 122.1, 121.3, 114.5, 98.3,
96.8, 55.6, 18.8, 14.7, 14.6, 11.4 ppm; HRMS (EI): m/z (%) calcd for
C33H36F6OS2Si: 654.1881; found 654.1874; elemental analysis: calcd (%)
for C33H36F6OS2Si (654.84): C 60.53, H 5.54; found: C 60.49, H 5.80.
1019, 989, 833, 763 cmÀ1 1H NMR (400 MHz, CDCl3): d=8.05 (d, J=
;
8.8 Hz, 6H), 7.57–7.52 (m, 12H), 7.49–7.45 (m, 4H), 7.31 (brs, 1H), 7.15
(brs, 1H), 6.93–6.90 (m, 2H), 4.38 (q, J=7.1 Hz, 6H), 3.84 (s, 3H), 2.21
(s, 12H), 1.99 (s, 3H), 1.97 (s, 3H) 1.40 ppm (t, J=7.1 Hz, 9H); 13C NMR
(100 MHz, CDCl3): d=166.6, 159.7, 153.9, 149.2, 142.4, 142.0, 141.6,
140.4, 133.2, 132.3, 131.9, 130.0, 128.9, 127.1, 126.3 (2C), 125.8, 125.5,
125.24, 125.18, 123.1, 122.8, 121.4 (2C), 114.5, 90.6, 89.2, 61.1, 55.5, 46.9,
46.8, 39.8, 39.5, 14.8, 14.7, 14.5 ppm; MS (70 eV): m/z (%): 1226 (30) [M+
À2H], 712 (10) 655 (10), 549 (17), 433 (10), 368 (17), 278 (15), 214 (18),
163 (20), 139 (42), 97 (57), 71 (65), 57 (100); HRMS (EI): m/z (%) calcd
for C73H60F6O7S2 [M+À2H]: 1226.3685; found: 1226.3727.
16: 1,2-Bis{[5-(4-methoxyphenyl)-2-methylthiophen-3-yl)-2-(5-phenyl-2-
methylthiopen-3-yl]-3,3,4,4,5,5-hexafluorocyclopentene}ethyne (16) was
isolated as a blue solid (4.8 mg, 4.9 mmol, 10%); mixture of isomers (O-
1
isomer : C-isomer ꢀ95:5 as determined by H NMR). C-isomer: Rf =0.14
(hexane/CH2Cl2, 5:1); O-isomer: Rf =0.10 (hexane/CH2Cl2, 5:1);
m.p.: 160–1628C; IR (ATR): n˜ =3075, 3033, 3000, 2956, 2924, 2853, 1725,
1706, 1610, 1554, 1515, 1473, 1465, 1440, 1337, 1273, 1253, 1192, 1138,
1113, 1091, 1053, 1035, 986, 899, 822 cmÀ1
;
1H NMR (400 MHz, CDCl3):
Dithienylethene-linker-conjugate 3: Method A: A flask was charged with
d=7.47–7.45 (m, J=8.8 Hz, 4H), 7.29 (brs, 2H), 7.13 (brs, 2H), 6.93–
6.91 (m, J=8.8 Hz, 4H), 3.84 (s, 6H), 1.94 (s, 6H), 1.93 ppm (s, 6H);
13C NMR (100 MHz, CDCl3): d=159.8, 144.2, 142.6, 140.5, 132.3, 127.1,
126.3, 125.6, 125.5, 121.3, 120.9, 114.6, 86.1, 55.6, 14.7 ppm (2C); MS
(70 eV): m/z (%): 970 (100) [M+], 546 (10), 312 (22), 191 (15), 130 (20),
119 (62), 105 (70), 91 (20), 77 (18); HRMS (EI): m/z (%) calcd for
C46H30F12O2S4: 970.0937; found: 970.0933.
iodo-tripod
96.2 mmol, 2.00 equiv), Pd
8
(50.0 mg, 48.0 mmol), dithienylethene 7b (55.0 mg,
2A(dba)3 (22.0 mg, 24.0 mmol, 50 mol%), P(o-
G
ACHTUNGTRENNUNG
tol)3 (43.8 mg, 144 mmol, 300 mol%) in Et3N (7.4 mL), and dry THF
(15 mL). The resulting reaction mixture was stirred at 608C for 24 h
under argon atmosphere (TLC monitoring), then cooled to room temper-
ature and poured into water (20 mL). Then, the reaction mixture was ex-
tracted with CH2Cl2 (3ꢄ20 mL). The combined organic layers were
washed with water (10 mL), dried (MgSO4), and evaporated in vacuo.
The crude product was purified by flash chromatography on silica gel
using hexane/EtOAc (4:1) to give compound 3 as a blue solid (27.0 mg,
18.1 mmol, 38%); mixture of isomers (O-isomer : C-isomer ꢀ 95:5 as de-
Dithienylethene-linker-conjugate 1: A thick-walled Schlenk tube was
evacuated, heated under vacuum, and refilled with argon three times.
Then, the Schlenk tube was charged under a positive pressure of argon
with dithienylethene 4 (35.0 mg, 68.7 mmol), ACHTUNTRGENNUG[PdCl2ACHTUNGTRENN(GUN CH3CN)2] (1.8 mg,
1
termined by H NMR).
6.9 mmol, 10 mol%), X-Phos (9.8 mg, 20.6 mmol, 30 mol%), K3PO4
(38.0 mg, 179 mmol, 2.60 equiv), and acetonitrile (0.14 mL). The bluish
suspension was degassed (5 min, ultrasound) and stirred for 30 min
before the tripod 5 (60.7 mg, 89.3 mmol, 1.30 equiv) was added. After-
wards, the Schlenk tube was sealed with a teflon valve, and the suspen-
sion was stirred for 4 h at 808C (TLC monitoring). The resulting suspen-
sion was allowed to reach room temperature, and was diluted with water
(15 mL) and EtOAc (15 mL). The aqueous phase was separated and ex-
tracted with EtOAc (3ꢄ15 mL). The combined organic layers were dried
(MgSO4) and evaporated in vacuo. The crude product was purified by
flash chromatography on silica gel using hexane/EtOAc (5:1) to give
product 1 as a bluish solid (52.0 mg, 45.1 mmol, 65%); mixture of isomers
(O-isomer : C-isomer ꢀ95:5 as determined by 1H NMR). O/C-isomer:
Method B: A thick-walled Schlenk tube was evacuated, heated under
vacuum, and refilled with argon three times. Then, the Schlenk tube was
charged under a positive pressure of argon with iodo-tripod 8 (25.0 mg,
24.0 mmol), ACHTUNGTRNENUG[PdCl2ACHTUNGTRNE(NUGN CH3CN)2] (0.6 mg, 2.4 mmol, 10 mol%), X-Phos
(3.4 mg, 7.2 mmol, 30 mol%), K3PO4 (13.3 mg, 62.4 mmol, 2.60 equiv), and
acetonitrile (240 mL). The bluish suspension was degassed (5 min, ultra-
sound) and stirred for 30 min before the dithienylethene 7b (17.9 mg,
31.2 mmol, 1.30 equiv) was added. Afterwards, the Schlenk tube was
sealed with a teflon valve, and the suspension was stirred for 20 h at
808C (TLC monitoring). The resulting suspension was allowed to reach
room temperature, and diluted with water (5 mL) and EtOAc (5 mL).
The aqueous phase was separated and extracted with EtOAc (3ꢄ5 mL).
1210
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Asian J. 2010, 5, 1202 – 1212